[1]
M. Mucenic, “Sofosbuvir, ribavirin and pegylated interferon for a daclatasvir-resistent genotype 3 hepatitis C virus: case report and review”, Rev. Inst. Med. Trop. São Paulo, vol. 61, p. e12, Feb. 2019, doi: 10.1590/S1678-9946201961012.